Yoko Satoh
Research Subjects
Research Interests
Yoko Satoh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Nambu
Department of Radiology, National Jewish Health, Denver, CO 80206, USA
2 shared publications - Hiroshi Onishi
Department of Therapeutic Radiology, University of Yamanashi, Yamanashi, Japan
2 shared publications - Eiichi Sawada
Department of Radiology, University of Yamanashi, 1110 Shimogato, Chuo, 409-3898, Japan
1 shared publication - Kan Marino
Department of Radiology, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan
1 shared publication - Kengo Kuriyama
Department of Radiation Oncology, University of Yamanashi, School of Medicine, Japan
1 shared publication - Licht Tominaga
Department of Radiology, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan
1 shared publication
Latest Publications
- Open Access
- 21 July 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 525
Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
In this retrospective study, the authors evaluated the prognostic value of whole-body total lesion glycolysis (WTLG) on FDG/PET images in metastatic breast cancer (MBC) patients.
- 21 July 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 525
Open AccessWhole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
In this retrospective study, the authors evaluated the prognostic value of whole-body total lesion glycolysis (WTLG) on FDG/PET images in metastatic breast cancer (MBC) patients.
- 1 November 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (11) , 3530-3534
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy
- 1 November 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (11) , 3530-3534
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy